<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <title>keep exceeding</title>
  
  
  <link href="/atom.xml" rel="self"/>
  
  <link href="http://yoursite.com/"/>
  <updated>2019-05-20T01:49:03.815Z</updated>
  <id>http://yoursite.com/</id>
  
  <author>
    <name>FancyXie</name>
    
  </author>
  
  <generator uri="http://hexo.io/">Hexo</generator>
  
  <entry>
    <title>PD-1治疗需要CXCR3</title>
    <link href="http://yoursite.com/2019/05/20/PD-1%E6%B2%BB%E7%96%97%E9%9C%80%E8%A6%81CXCR3/"/>
    <id>http://yoursite.com/2019/05/20/PD-1治疗需要CXCR3/</id>
    <published>2019-05-20T01:36:46.000Z</published>
    <updated>2019-05-20T01:49:03.815Z</updated>
    
    <content type="html"><![CDATA[<p><a href="https://www.cell.com/immunity/fulltext/S1074-7613(19" target="_blank" rel="noopener">Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy</a>30190-6?rss=yes)</p><a id="more"></a><h2 id="Abstract"><a href="#Abstract" class="headerlink" title="Abstract"></a>Abstract</h2><p>作者发现缺乏趋化因子受体CXCR3的荷瘤小鼠对抗PD-1治疗的反应很差。 在用抗PD-1处理的荷瘤小鼠中，CXCR3及其配体CXCL9对于productive CD8 + T细胞应答是关键的，但对于CD8 + T细胞向肿瘤的浸润不是必需的。瘤内CD103 +树突细胞产生的CXCL9促进了抗PD-1诱导的抗肿瘤反应，表明CXCR3促进肿瘤微环境中的DC-T细胞相互作用。小鼠肿瘤和黑素瘤患者血浆中的CXCR3配体是对抗PD-1的临床反应的指标，并且在非反应性小鼠肿瘤中诱导CXCL19表达可以促进抗PD-1的反应性。综上：CXCR3趋化因子系统是对PD-1阻断敏感性的生物标志物，并且增强该趋化因子系统的肿瘤内功能可以改善clinical outcome</p><p><img src="https://marlin-prod.literatumonline.com/cms/attachment/10b461fe-0506-43fb-9897-46bc720b5b1a/fx1_lrg.jpg" alt></p>]]></content>
    
    <summary type="html">
    
      &lt;p&gt;&lt;a href=&quot;https://www.cell.com/immunity/fulltext/S1074-7613(19&quot; target=&quot;_blank&quot; rel=&quot;noopener&quot;&gt;Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy&lt;/a&gt;30190-6?rss=yes)&lt;/p&gt;
    
    </summary>
    
      <category term="paper" scheme="http://yoursite.com/categories/paper/"/>
    
    
      <category term="immunity" scheme="http://yoursite.com/tags/immunity/"/>
    
  </entry>
  
  <entry>
    <title>TGF-β--肿瘤免疫</title>
    <link href="http://yoursite.com/2019/05/17/TGF-%CE%B2--%E8%82%BF%E7%98%A4%E5%85%8D%E7%96%AB/"/>
    <id>http://yoursite.com/2019/05/17/TGF-β--肿瘤免疫/</id>
    <published>2019-05-17T08:12:22.000Z</published>
    <updated>2019-05-20T01:36:50.175Z</updated>
    
    <content type="html"><![CDATA[<h1 id="概况"><a href="#概况" class="headerlink" title="概况"></a>概况</h1><p>TGF-β在肿瘤早期可以抑制肿瘤生长，而在后期则转变成一个肿瘤促进因子。</p><p>晚期，大多数肿瘤细胞均可分泌TGF-β，一旦TGF-β水平升高便可以<strong>阻断未成熟的T细胞向Th1细胞分化，促进其向Treg亚群的转化，并抑制树突状细胞的抗原递呈功能</strong>，从而导致肿瘤细胞的免疫逃逸。随着肿瘤的发展，肿瘤细胞内TGF-β受体或其下游的<em>Smad</em>基因突变积累，其抑制作用减弱。并且<strong>TGF-β信号促进上皮细胞间质转型</strong>（Epithelial-Mesenchymal Transition, EMT），这个过程使具有极性的上皮细胞转化为具有活动能力的间质细胞，从而获得侵袭和迁移的能力，这个转化过程在肿瘤的发生、恶化及转移中非常重要。肿瘤转移是导致癌症病人死亡的一个非常重要的原因，实体瘤患者中高达90%的患者死于肿瘤转移。</p><h1 id="文献"><a href="#文献" class="headerlink" title="文献"></a>文献</h1><h2 id="TGFβ-drives-immune-evasion-in-genetically-reconstituted-colon-cancer-metastasis"><a href="#TGFβ-drives-immune-evasion-in-genetically-reconstituted-colon-cancer-metastasis" class="headerlink" title="TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis"></a>TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis</h2>]]></content>
    
    <summary type="html">
    
      
      
        &lt;h1 id=&quot;概况&quot;&gt;&lt;a href=&quot;#概况&quot; class=&quot;headerlink&quot; title=&quot;概况&quot;&gt;&lt;/a&gt;概况&lt;/h1&gt;&lt;p&gt;TGF-β在肿瘤早期可以抑制肿瘤生长，而在后期则转变成一个肿瘤促进因子。&lt;/p&gt;
&lt;p&gt;晚期，大多数肿瘤细胞均可分泌TGF-β，一旦TGF-
      
    
    </summary>
    
      <category term="paper" scheme="http://yoursite.com/categories/paper/"/>
    
    
      <category term="immunity" scheme="http://yoursite.com/tags/immunity/"/>
    
  </entry>
  
  <entry>
    <title>统计</title>
    <link href="http://yoursite.com/2019/05/15/%E7%BB%9F%E8%AE%A1/"/>
    <id>http://yoursite.com/2019/05/15/统计/</id>
    <published>2019-05-15T02:54:31.000Z</published>
    <updated>2019-05-15T02:59:22.220Z</updated>
    
    <content type="html"><![CDATA[<h1 id="生存曲线比较-Log-Rank检验"><a href="#生存曲线比较-Log-Rank检验" class="headerlink" title="生存曲线比较: Log Rank检验"></a>生存曲线比较: Log Rank检验</h1><blockquote><p>1、SPSS中的分析方法的名称为Log Rank和Breslow；SAS中相对应的为Log Rank和Wilcoxon。Breslow法即广义Wilcoxon法。Log Rank检验在实际工作中应用较多。</p></blockquote><p>2、Log Rank检验给结局事件的远期差别更大的权重，即对远期差异敏感；而Breslow检验给结局事件的近期差别更大的权重。因此，对于一开始粘在一起，随时时间的推移越拉越开的生存曲线，Log Rank检验较Breslow检验容易得到差异有显著性的结果；反之，对于一开始相差较大，随着时间的推移反而越来越近的生存曲线，Breslow法容易得到差异有显著性的结果。</p><p>3、用Log Rank检验比较时，要求各组生存曲线不能交叉，如果有交叉则提示可能存在混杂因素，此时应进行样本分层或多因素的方法校正混杂因素。</p><p><a href="https://zhuanlan.zhihu.com/p/24410512" target="_blank" rel="noopener">生存曲线比较：KM法及Log Rank检验（实例+SPSS）</a></p>]]></content>
    
    <summary type="html">
    
      
      
        &lt;h1 id=&quot;生存曲线比较-Log-Rank检验&quot;&gt;&lt;a href=&quot;#生存曲线比较-Log-Rank检验&quot; class=&quot;headerlink&quot; title=&quot;生存曲线比较: Log Rank检验&quot;&gt;&lt;/a&gt;生存曲线比较: Log Rank检验&lt;/h1&gt;&lt;blockquote
      
    
    </summary>
    
      <category term="basic" scheme="http://yoursite.com/categories/basic/"/>
    
    
      <category term="statistics" scheme="http://yoursite.com/tags/statistics/"/>
    
  </entry>
  
  <entry>
    <title>pancreatic CAF associated papers</title>
    <link href="http://yoursite.com/2019/05/15/pancreatic-CAF-associated-papers/"/>
    <id>http://yoursite.com/2019/05/15/pancreatic-CAF-associated-papers/</id>
    <published>2019-05-15T02:44:13.000Z</published>
    <updated>2019-05-15T02:56:12.192Z</updated>
    
    <summary type="html">
    
    </summary>
    
      <category term="paper" scheme="http://yoursite.com/categories/paper/"/>
    
    
      <category term="cancer" scheme="http://yoursite.com/tags/cancer/"/>
    
  </entry>
  
  <entry>
    <title>R: Error in dyn.load(file, DLLpath = DLLpath, …)</title>
    <link href="http://yoursite.com/2019/05/12/R-Error-in-dyn-load-file-DLLpath-DLLpath-%E2%80%A6/"/>
    <id>http://yoursite.com/2019/05/12/R-Error-in-dyn-load-file-DLLpath-DLLpath-…/</id>
    <published>2019-05-12T14:05:26.000Z</published>
    <updated>2019-05-12T14:07:21.342Z</updated>
    
    <content type="html"><![CDATA[<figure class="highlight r"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br><span class="line">5</span><br></pre></td><td class="code"><pre><span class="line">Re-installing the package was enough to getting it working again.</span><br><span class="line">$ sudo R</span><br><span class="line">&gt; install.packages(<span class="string">"rgdal"</span>)</span><br><span class="line">&gt; quit()</span><br><span class="line">$ exit</span><br></pre></td></tr></table></figure><p><a href="https://stackoverflow.com/questions/38943764/r-error-in-dyn-loadfile-dllpath-dllpath" target="_blank" rel="noopener">https://stackoverflow.com/questions/38943764/r-error-in-dyn-loadfile-dllpath-dllpath</a></p>]]></content>
    
    <summary type="html">
    
      
      
        &lt;figure class=&quot;highlight r&quot;&gt;&lt;table&gt;&lt;tr&gt;&lt;td class=&quot;gutter&quot;&gt;&lt;pre&gt;&lt;span class=&quot;line&quot;&gt;1&lt;/span&gt;&lt;br&gt;&lt;span class=&quot;line&quot;&gt;2&lt;/span&gt;&lt;br&gt;&lt;span class=&quot;li
      
    
    </summary>
    
      <category term="erro" scheme="http://yoursite.com/categories/erro/"/>
    
    
      <category term="R" scheme="http://yoursite.com/tags/R/"/>
    
  </entry>
  
  <entry>
    <title>R install.packages returns “failed to create lock directory</title>
    <link href="http://yoursite.com/2019/05/12/R-install-packages-returns-%E2%80%9Cfailed-to-create-lock-directory/"/>
    <id>http://yoursite.com/2019/05/12/R-install-packages-returns-“failed-to-create-lock-directory/</id>
    <published>2019-05-12T13:55:30.000Z</published>
    <updated>2019-05-12T14:07:33.257Z</updated>
    
    <content type="html"><![CDATA[<figure class="highlight r"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br></pre></td><td class="code"><pre><span class="line">it was related to multiple distributed R processes spread over SGE cluster trying to interact with the package index files <span class="keyword">in</span> LIB_PATH and the latency of cleaning up lock file on NFS file system</span><br><span class="line">install.packages(<span class="string">"Rcpp"</span>, dependencies=<span class="literal">TRUE</span>, INSTALL_opts = c(<span class="string">'--no-lock'</span>))</span><br></pre></td></tr></table></figure><p>This happens when your last package installation has interrupted abnormally. to fix this you should remove the locked file</p><figure class="highlight r"><table><tr><td class="gutter"><pre><span class="line">1</span><br></pre></td><td class="code"><pre><span class="line">unlink(<span class="string">"/home/me/src/Rlibs/00LOCK-Rcpp"</span>, recursive = <span class="literal">TRUE</span>)</span><br></pre></td></tr></table></figure><p><a href="https://stackoverflow.com/questions/14382209/r-install-packages-returns-failed-to-create-lock-directory" target="_blank" rel="noopener">https://stackoverflow.com/questions/14382209/r-install-packages-returns-failed-to-create-lock-directory</a></p>]]></content>
    
    <summary type="html">
    
      
      
        &lt;figure class=&quot;highlight r&quot;&gt;&lt;table&gt;&lt;tr&gt;&lt;td class=&quot;gutter&quot;&gt;&lt;pre&gt;&lt;span class=&quot;line&quot;&gt;1&lt;/span&gt;&lt;br&gt;&lt;span class=&quot;line&quot;&gt;2&lt;/span&gt;&lt;br&gt;&lt;/pre&gt;&lt;/td&gt;&lt;td 
      
    
    </summary>
    
      <category term="erro" scheme="http://yoursite.com/categories/erro/"/>
    
    
      <category term="R" scheme="http://yoursite.com/tags/R/"/>
    
  </entry>
  
  <entry>
    <title>李梢--单细胞转录组发现早期胃癌特异标记基因</title>
    <link href="http://yoursite.com/2019/05/12/%E6%9D%8E%E6%A2%A2-%E5%8D%95%E7%BB%86%E8%83%9E%E8%BD%AC%E5%BD%95%E7%BB%84%E5%8F%91%E7%8E%B0%E6%97%A9%E6%9C%9F%E8%83%83%E7%99%8C%E7%89%B9%E5%BC%82%E6%A0%87%E8%AE%B0%E5%9F%BA%E5%9B%A0/"/>
    <id>http://yoursite.com/2019/05/12/李梢-单细胞转录组发现早期胃癌特异标记基因/</id>
    <published>2019-05-12T08:42:05.000Z</published>
    <updated>2019-05-13T14:37:34.813Z</updated>
    
    <content type="html"><![CDATA[<p><a href="https://doi.org/10.1016/j.celrep.2019.04.052" target="_blank" rel="noopener">Dissecting the Single-Cell Transcriptome Network Underlying Gastric Premalignant Lesions and Early Gastric Cancer</a></p><h2 id="Abstract"><a href="#Abstract" class="headerlink" title="Abstract"></a>Abstract</h2><ul><li><p>constructed a single-cell atlas for 32,332 high-quality cells from gastric antral mucosa biopsies of patients spanning a cascade of gastric premalignant lesions and early gastric cancer (EGC) using single-cell RNA sequencing</p></li><li><p>We found that gland mucous cells tended to acquire an intestinal-like stem cell phenotype during metaplasia, and we identified <strong>OR51E1</strong> as a marker for unique endocrine cells in the early-malignant lesion.</p></li><li><p>We also found that <strong>HES6</strong> might mark the pre-goblet cell cluster, potentially aiding identification of metaplasia at the early stage.</p></li></ul><h2 id="RESULTS"><a href="#RESULTS" class="headerlink" title="RESULTS"></a>RESULTS</h2><h3 id="A-Single-Cell-Atlas-of-Premalignant-Gastric-Antral-Mucosae-and-EGC"><a href="#A-Single-Cell-Atlas-of-Premalignant-Gastric-Antral-Mucosae-and-EGC" class="headerlink" title="A Single-Cell Atlas of Premalignant Gastric Antral Mucosae and EGC"></a>A Single-Cell Atlas of Premalignant Gastric Antral Mucosae and EGC</h3><p><img src="C:\Users\feng\AppData\Roaming\Typora\typora-user-images\1557755753032.png" alt="1557755753032"></p><ul><li>the atlas mainly comprised epithelial cells (<strong>EPCAM, KRT18, and MUC1</strong>) and non-epithelial cells (<strong>VIM and PTPRC</strong>)</li><li><font color="#F08080"><strong>epithelial cells</strong></font> mainly consisted of gastric epithelial cells, including antral <strong>basal gland mucous cells</strong> (GMCs, marked as MUC6 and TFF2), <strong>pit mucous cells </strong>(PMCs, marked as MUC5AC and TFF1), <strong>chief cells </strong>(PGA4 and PGA3), and <strong>enteroendocrine cells</strong> (CHGA and CHGB)  GMC：基底腺粘液细胞  PMC：坑粘液细胞 chief cell ：主细胞   肠内分泌细胞</li><li>proliferative cells (PCs)  MKI67 and BRIC5</li><li>cancer cells  CEACAM5 and CEACAM6</li><li>metaplastic stem-like cell (MSC)：elevated expression of the intestinal stem cell markers, including OLFM4, EPHB2, and SOX9</li><li><font color="#F08080"><strong>non-epithelial cell lineages</strong></font> comprised T cells (CD2 and CD3D), B cells (CD79A), macrophages (CSF1R and CD68), fibroblasts (DCN and PDPN), smooth muscle cells (SMCs, marked as ACTA2), endothelial cells (ECs, marked as VWF and ENG), and mast cells (TPSAB1)</li><li>FigD:  plot the cell of origin for some mediators in the cytokines and the nuclear factor kB (NF-kB) signaling pathway</li></ul><p>we found that macrophages might be a dominant source of <strong>interleukin-1B (IL-1B)</strong>, whose genotype was reported to confer a greater risk of GC, and <strong>PTGS2</strong>, which plays a crucial role in mediating the inflammatory process through the activation of NF-kB</p><h4 id="H-pylori-幽门螺旋杆菌-的影响"><a href="#H-pylori-幽门螺旋杆菌-的影响" class="headerlink" title="H. pylori(幽门螺旋杆菌)的影响"></a>H. pylori(幽门螺旋杆菌)的影响</h4><p><img src="https://i.loli.net/2019/05/13/5cd97a2caf31b74339.jpg" alt></p>]]></content>
    
    <summary type="html">
    
      
      
        &lt;p&gt;&lt;a href=&quot;https://doi.org/10.1016/j.celrep.2019.04.052&quot; target=&quot;_blank&quot; rel=&quot;noopener&quot;&gt;Dissecting the Single-Cell Transcriptome Network Un
      
    
    </summary>
    
      <category term="paper" scheme="http://yoursite.com/categories/paper/"/>
    
    
      <category term="cancer" scheme="http://yoursite.com/tags/cancer/"/>
    
  </entry>
  
  <entry>
    <title>python dataframe 获取行名和列名</title>
    <link href="http://yoursite.com/2019/05/09/python-dataframe-%E8%8E%B7%E5%8F%96%E8%A1%8C%E5%90%8D%E5%92%8C%E5%88%97%E5%90%8D/"/>
    <id>http://yoursite.com/2019/05/09/python-dataframe-获取行名和列名/</id>
    <published>2019-05-09T14:32:53.000Z</published>
    <updated>2019-05-09T14:36:10.514Z</updated>
    
    <content type="html"><![CDATA[<figure class="highlight python"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br></pre></td><td class="code"><pre><span class="line">dfname._stat_axis.values.tolist() <span class="comment"># 行名称</span></span><br><span class="line"></span><br><span class="line">dfname.columns.values.tolist()    <span class="comment"># 列名称</span></span><br></pre></td></tr></table></figure>]]></content>
    
    <summary type="html">
    
      
      
        &lt;figure class=&quot;highlight python&quot;&gt;&lt;table&gt;&lt;tr&gt;&lt;td class=&quot;gutter&quot;&gt;&lt;pre&gt;&lt;span class=&quot;line&quot;&gt;1&lt;/span&gt;&lt;br&gt;&lt;span class=&quot;line&quot;&gt;2&lt;/span&gt;&lt;br&gt;&lt;span clas
      
    
    </summary>
    
    
      <category term="python" scheme="http://yoursite.com/tags/python/"/>
    
  </entry>
  
  <entry>
    <title>pandas.DataFrame更改列名</title>
    <link href="http://yoursite.com/2019/05/09/pandas-DataFrame%E6%9B%B4%E6%94%B9%E5%88%97%E5%90%8D/"/>
    <id>http://yoursite.com/2019/05/09/pandas-DataFrame更改列名/</id>
    <published>2019-05-09T14:28:59.000Z</published>
    <updated>2019-05-09T14:35:39.390Z</updated>
    
    <content type="html"><![CDATA[<figure class="highlight python"><table><tr><td class="gutter"><pre><span class="line">1</span><br><span class="line">2</span><br><span class="line">3</span><br><span class="line">4</span><br><span class="line">5</span><br></pre></td><td class="code"><pre><span class="line"></span><br><span class="line">df.columns.values <span class="comment">## 显示每列的名称</span></span><br><span class="line">df.rename(columns=&#123; df.columns[<span class="number">2</span>]: <span class="string">"new name"</span> &#125;, inplace=<span class="literal">True</span>) <span class="comment">## 将第三列的列名改为'new name'</span></span><br><span class="line">df.columns = [<span class="string">'col_1'</span>, <span class="string">'col_2'</span>, <span class="string">'col_3'</span>]  <span class="comment">## 假如df一共有三列，你想把所有列名依次改为'col_1', 'col_2', 'col_3'</span></span><br><span class="line">df = df.rename(columns=&#123;<span class="string">'col_1'</span>: <span class="string">'col_a'</span>&#125;)</span><br></pre></td></tr></table></figure>]]></content>
    
    <summary type="html">
    
      
      
        &lt;figure class=&quot;highlight python&quot;&gt;&lt;table&gt;&lt;tr&gt;&lt;td class=&quot;gutter&quot;&gt;&lt;pre&gt;&lt;span class=&quot;line&quot;&gt;1&lt;/span&gt;&lt;br&gt;&lt;span class=&quot;line&quot;&gt;2&lt;/span&gt;&lt;br&gt;&lt;span clas
      
    
    </summary>
    
    
      <category term="python" scheme="http://yoursite.com/tags/python/"/>
    
  </entry>
  
  <entry>
    <title>生物信息--山东大学</title>
    <link href="http://yoursite.com/2019/05/08/%E7%94%9F%E7%89%A9%E4%BF%A1%E6%81%AF-%E5%B1%B1%E4%B8%9C%E5%A4%A7%E5%AD%A6/"/>
    <id>http://yoursite.com/2019/05/08/生物信息-山东大学/</id>
    <published>2019-05-08T12:25:04.000Z</published>
    <updated>2019-05-20T02:09:05.393Z</updated>
    
    <content type="html"><![CDATA[<h2 id="生物数据库"><a href="#生物数据库" class="headerlink" title="生物数据库"></a>生物数据库</h2><h2 id="分类"><a href="#分类" class="headerlink" title="分类"></a>分类</h2><h3 id="核酸数据库"><a href="#核酸数据库" class="headerlink" title="核酸数据库"></a>核酸数据库</h3><p>一级：GeneBank ENA DDBJ</p><p>蛋白数据库：一级   二级</p><p>专用数据库</p>]]></content>
    
    <summary type="html">
    
      
      
        &lt;h2 id=&quot;生物数据库&quot;&gt;&lt;a href=&quot;#生物数据库&quot; class=&quot;headerlink&quot; title=&quot;生物数据库&quot;&gt;&lt;/a&gt;生物数据库&lt;/h2&gt;&lt;h2 id=&quot;分类&quot;&gt;&lt;a href=&quot;#分类&quot; class=&quot;headerlink&quot; title=&quot;分类&quot;&gt;&lt;/a&gt;分
      
    
    </summary>
    
    
      <category term="bioinformatic" scheme="http://yoursite.com/tags/bioinformatic/"/>
    
  </entry>
  
  <entry>
    <title>Gal1 inhibit PDAC via tumor-stroma crosstalk(PNAS_2017)</title>
    <link href="http://yoursite.com/2019/04/30/Gal1-inhibit-PDAC-via-tumor-stroma-crosstalk-PNAS-2017/"/>
    <id>http://yoursite.com/2019/04/30/Gal1-inhibit-PDAC-via-tumor-stroma-crosstalk-PNAS-2017/</id>
    <published>2019-04-30T02:00:48.000Z</published>
    <updated>2019-04-30T14:20:49.472Z</updated>
    
    <content type="html"><![CDATA[<p><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910865/" target="_blank" rel="noopener">Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk</a></p><a id="more"></a>]]></content>
    
    <summary type="html">
    
      &lt;p&gt;&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910865/&quot; target=&quot;_blank&quot; rel=&quot;noopener&quot;&gt;Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk&lt;/a&gt;&lt;/p&gt;
    
    </summary>
    
      <category term="paper" scheme="http://yoursite.com/categories/paper/"/>
    
    
      <category term="cancer" scheme="http://yoursite.com/tags/cancer/"/>
    
  </entry>
  
  <entry>
    <title>Single-Cell-Transcriptomics-of-Human-and-Mouse-Lung-Cancers-Reveals-Conserved-Myeloid-Populations-across-Individuals-and-Species</title>
    <link href="http://yoursite.com/2019/04/27/Single-Cell-Transcriptomics-of-Human-and-Mouse-Lung-Cancers-Reveals-Conserved-Myeloid-Populations-across-Individuals-and-Species/"/>
    <id>http://yoursite.com/2019/04/27/Single-Cell-Transcriptomics-of-Human-and-Mouse-Lung-Cancers-Reveals-Conserved-Myeloid-Populations-across-Individuals-and-Species/</id>
    <published>2019-04-27T05:48:40.000Z</published>
    <updated>2019-04-27T05:48:40.325Z</updated>
    
    <summary type="html">
    
    </summary>
    
    
  </entry>
  
  <entry>
    <title>Treg中HPGD发挥免疫抑制功能（通过pparg通路）</title>
    <link href="http://yoursite.com/2019/04/25/Treg%E4%B8%ADHPGD%E5%8F%91%E6%8C%A5%E5%85%8D%E7%96%AB%E6%8A%91%E5%88%B6%E5%8A%9F%E8%83%BD%EF%BC%88%E9%80%9A%E8%BF%87pparg%E9%80%9A%E8%B7%AF%EF%BC%89/"/>
    <id>http://yoursite.com/2019/04/25/Treg中HPGD发挥免疫抑制功能（通过pparg通路）/</id>
    <published>2019-04-25T06:21:16.000Z</published>
    <updated>2019-05-20T02:08:15.875Z</updated>
    
    <content type="html"><![CDATA[<p><a href="https://doi.org/10.1016/j.immuni.2019.03.014" target="_blank" rel="noopener">Enzymatic Activity of HPGD in Treg Cells Suppresses Tconv Cells to Maintain Adipose Tissue Homeostasis and Prevent Metabolic Dysfunction</a></p><a id="more"></a><h2 id="Highlights"><a href="#Highlights" class="headerlink" title="Highlights"></a>Highlights</h2><ul><li>HPGD is specifically upregulated in Treg cells and confers suppressive capabilities</li><li>HPGD-induced Tconv cell suppression is in part mediated by PPARγ signaling</li><li>HPGD expression in Treg cells is vital for VAT homeostasis and metabolic regulation</li><li>T2D patients have a reduced Treg cell fraction expressing lower amounts of HPGD</li></ul><h2 id="Summary"><a href="#Summary" class="headerlink" title="Summary"></a>Summary</h2><p>Regulatory T cells (Treg cells) are important for preventing autoimmunity and maintaining tissue homeostasis, but whether Treg cells can adopt tissue- or immune-context-specific suppressive mechanisms is unclear. Here, we found that the enzyme hydroxyprostaglandin dehydrogenase (HPGD), which catabolizes prostaglandin E 2 (PGE 2) into the metabolite 15-keto PGE 2, was highly expressed in Treg cells, particularly those in visceral adipose tissue (VAT). <strong>Nuclear receptor peroxisome proliferator-activated receptor-γ (PPARγ)-induced HPGD expression in VAT Treg cells, and consequential Treg-cell-mediated generation of 15-keto PGE 2 suppressed conventional T cell activation and proliferation</strong>. Conditional deletion of Hpgd in mouse Treg cells resulted in the accumulation of functionally impaired Treg cells specifically in VAT, causing local inflammation and systemic insulin resistance. Consistent with this mechanism, humans with type 2 diabetes showed decreased HPGD expression in Treg cells. These data indicate that HPGD-mediated suppression is a tissue- and context-dependent suppressive mechanism used by Treg cells to maintain adipose tissue homeostasis.</p>]]></content>
    
    <summary type="html">
    
      &lt;p&gt;&lt;a href=&quot;https://doi.org/10.1016/j.immuni.2019.03.014&quot; target=&quot;_blank&quot; rel=&quot;noopener&quot;&gt;Enzymatic Activity of HPGD in Treg Cells Suppresses Tconv Cells to Maintain Adipose Tissue Homeostasis and Prevent Metabolic Dysfunction&lt;/a&gt;&lt;/p&gt;
    
    </summary>
    
      <category term="paper" scheme="http://yoursite.com/categories/paper/"/>
    
    
      <category term="immunity" scheme="http://yoursite.com/tags/immunity/"/>
    
  </entry>
  
  <entry>
    <title>免疫学原理</title>
    <link href="http://yoursite.com/2019/04/20/%E5%85%8D%E7%96%AB%E5%AD%A6%E5%8E%9F%E7%90%86/"/>
    <id>http://yoursite.com/2019/04/20/免疫学原理/</id>
    <published>2019-04-20T12:14:05.000Z</published>
    <updated>2019-04-27T05:56:07.251Z</updated>
    
    <content type="html"><![CDATA[<p>非淋巴细胞和固有淋巴细胞  <a href="https://mubu.com/doc/dwcLe46HQw" target="_blank" rel="noopener">https://mubu.com/doc/dwcLe46HQw</a></p><p>免疫原与免疫球蛋白 <a href="https://mubu.com/doc/mpILeMq500" target="_blank" rel="noopener">https://mubu.com/doc/mpILeMq500</a></p><p>主要组织相容性抗原 <a href="https://mubu.com/doc/kcgK6-1kE0" target="_blank" rel="noopener">https://mubu.com/doc/kcgK6-1kE0</a></p><p>固有免疫 <a href="https://mubu.com/doc/gklhh9gUi0" target="_blank" rel="noopener">https://mubu.com/doc/gklhh9gUi0</a></p>]]></content>
    
    <summary type="html">
    
      
      
        &lt;p&gt;非淋巴细胞和固有淋巴细胞  &lt;a href=&quot;https://mubu.com/doc/dwcLe46HQw&quot; target=&quot;_blank&quot; rel=&quot;noopener&quot;&gt;https://mubu.com/doc/dwcLe46HQw&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;免疫原与免疫球
      
    
    </summary>
    
      <category term="basic" scheme="http://yoursite.com/categories/basic/"/>
    
    
      <category term="immunity" scheme="http://yoursite.com/tags/immunity/"/>
    
  </entry>
  
  <entry>
    <title>Negative Co-stimulation 控制T细胞分化</title>
    <link href="http://yoursite.com/2019/04/18/Negative%20Co-stimulation%20%E6%8E%A7%E5%88%B6T%E7%BB%86%E8%83%9E%E5%88%86%E5%8C%96/"/>
    <id>http://yoursite.com/2019/04/18/Negative Co-stimulation 控制T细胞分化/</id>
    <published>2019-04-18T05:33:41.000Z</published>
    <updated>2019-05-20T02:08:55.195Z</updated>
    
    <content type="html"><![CDATA[<p><a href="https://doi.org/10.1016/j.immuni.2019.03.004" target="_blank" rel="noopener">Negative Co-stimulation Constrains T Cell Differentiation by Imposing Boundaries on Possible Cell States</a></p><p>Immunity, 201904</p><p>T cell differentiation generates a wide range of specialized cell types; however, how the range of attainable cell states (i.e., phenotypes) is determined remains an open question. Given that T cell differentiation is tightly linked to TCR signal strength, the authors hypothesized that attenuation of downstream TCR signaling by CTLA-4 might also regulate differentiation. In order to verify this, the authors profiled lymphocytes derived from <em>Ctla4-/-</em> and littermate control mice via mass cytometry and subsequently used clustering methods to classify T cell populations. t-SNE visualization illustrated changes in T cell population frequencies and phenotypes in <em>Ctla4-/-</em> mice, but no differences between <em>Ctla4+/+</em> and <em>Ctla4+/-</em> mice were apparent. Populations that were only observed in <em>Ctla4-/-</em> mice were entirely contained within the CD4+ compartment. These enriched CD4+ T cell populations expressed high amounts of CD44 and inducible co-stimulatory molecule (ICOS) but displayed variable levels of other activation markers and lineage transcription factors. For example, the frequency of terminally differentiated (TBET+EOMES+CD44+CD62L+) CD8+ T cells increased in <em>Ctla4-/-</em> mice. Similarly, an ICOS+ Treg cell population that is very minor in CTLA-4 competent mice expanded in frequency in <em>Ctla4-/-</em> mice, whereas other Treg cell populations remained stable or contracted. These findings contrasted with the effects on CD8+ T cells, in which loss of CTLA-4 modulated expression levels (e.g., EOMES, IRF4, and CXCR3), but no CD8+ T cell clusters, was detected only in <em>Ctla4-/-</em> mice. This suggests that CTLA-4 limits CD4+ T cell phenotypes but not those of CD8+ T cells. Next, the authors concurrently assessed changes in 5-iodo-deoxyuridine (IdU) incorporation and changes in frequency in T cell subsets due to loss of CTLA-4 which suggested that there was no correlation between the change in frequency of each T cell subset and the respective changes in IdU incorporation. The phenomenon revealed above raised a question that whether loss of CTLA-4-mediated negative feedback allows cells to occupy otherwise unattainable phenotypic states. Archetypal analysis, an unsupervised computational approach used to identify optimal phenotypes associated with specific biological phenomena at the organismal and single-cell level, helped researchers identified phenotypic boundary and reveals that loss of CTLA-4 expands CD4+ but not CD8+ T cell phenotypic space. Next, because ICOS was highly expressed by phenotypically expanded T cells and antibody blockade of ICOS attenuates T cell activity in <em>Ctla4-/-</em> mice, researchers tested whether ICOS is necessary for the generation of aberrant populations. As a result, all T cell populations identified in <em>Ctla4-/-Icos+/-</em> mice were present in <em>Ctla4-/-Icos-/-</em> mice, indicating that although ICOS is highly expressed on phenotypically expanded subsets, it is not required for their development.</p><p>immunized <em>Ctla4-/-</em> and littermate controls with ovalbumin in complete Freund’s adjuvant (CFA) indicated that extension of phenotypic limits derives directly from loss of CTLA-4 rather than indirect effects of its deletion. Then, analysis of TCRβ repertoire of thymic and LN tissue from <em>Ctla4-/-</em> and littermate control mice revealed that no major molecular defects in thymic T cell repertoire or the frequency of productive rearrangements were detected. In contrast, T cell clonality increased in <em>Ctla4-/-</em> LN tissue. Increased clonality was accompanied by decreased average CDR3 length, in part resulting from a decrease in N1 and N2 nucleotides inserted at V-D and D-J junctions. On the other hand, analysis of PD1 suggested that PD1 mainly affected CD8+ populations but the subtle expansion of CD8+ T cell phenotype limits due to loss of PD-1 appears to be age dependent and most likely relies on the prior induction of an immune response. Finally, the authors used mass cytometry data to reconstruct differentiation trajectories between the naive CD4+ T cell archetype and each differentiated CD4+ T cell archetype. Along the trajectory, the authors investigated that a subset of markers (such as PD1) expression continued to increase beyond the boundary which suggested that a primary mechanism by which CTLA-4 restrains T cell phenotypes is through imposing maximal limits on already active pathways.</p><p>In summary, this paper revealed that (1) T cell negative co-stimulation regulates the limits of T cell differentiation, a role related to but distinct from its regulation of T cell activation; (2) CTLA-4 enforces boundaries on CD4+ T cell phenotypes; (3) PD-1 subtly restrains CD8+ T cell phenotypes; and (4) CTLA-4 constrains T cell phenotypes by imposing maximal expression limits during differentiation. These finding support the “nuanced model” in which T cell subsets represent a continuum of interrelated phenotypic states, defined by ratios of co-expression of lineage transcription factors, rather than discrete lineages. It remains to be assessed whether the expanded phenotypes represent stable terminally differentiated states or rather transient intermediate states not normally attainable.</p><p><img src="https://i.loli.net/2019/04/27/5cc3ee0aa5855.jpg" alt></p>]]></content>
    
    <summary type="html">
    
      
      
        &lt;p&gt;&lt;a href=&quot;https://doi.org/10.1016/j.immuni.2019.03.004&quot; target=&quot;_blank&quot; rel=&quot;noopener&quot;&gt;Negative Co-stimulation Constrains T Cell Different
      
    
    </summary>
    
      <category term="daily" scheme="http://yoursite.com/categories/daily/"/>
    
    
      <category term="immunity" scheme="http://yoursite.com/tags/immunity/"/>
    
  </entry>
  
  <entry>
    <title>tool</title>
    <link href="http://yoursite.com/2019/04/13/tool/"/>
    <id>http://yoursite.com/2019/04/13/tool/</id>
    <published>2019-04-13T14:29:48.000Z</published>
    <updated>2019-04-27T05:55:50.124Z</updated>
    
    <content type="html"><![CDATA[<h2 id="CytoSPADE"><a href="#CytoSPADE" class="headerlink" title="CytoSPADE"></a>CytoSPADE</h2><blockquote><p>A high-performance implementation of an interface for the Spanning-tree Progression Analysis of Density-normalized Events algorithm for tree-based analysis and visualization of this high-dimensional cytometry data</p></blockquote><a id="more"></a><h2 id="PhenoGraph"><a href="#PhenoGraph" class="headerlink" title="PhenoGraph"></a>PhenoGraph</h2><blockquote><p><a href="http://www.cell.com/cell/abstract/S0092-8674(15" target="_blank" rel="noopener">PhenoGraph</a>00637-6) is a clustering method designed for high-dimensional single-cell data. It works by creating a graph (“network”) representing phenotypic similarities between cells and then identifying communities in this graph.</p></blockquote><p><a href="https://www.ncbi.nlm.nih.gov/pubmed/28865188" target="_blank" rel="noopener">PhenoGraph and viSNE facilitate the identification of abnormal T-cell populations in routine clinical flow cytometric data.</a></p><p><a href="https://www.cell.com/cell/fulltext/S0092-8674(15" target="_blank" rel="noopener">Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis</a>00637-6&gt;)</p><h2 id="Louvain"><a href="#Louvain" class="headerlink" title="Louvain"></a>Louvain</h2><p><img src="https://i.loli.net/2019/04/18/5cb81b8c5430c.jpg" alt></p><p><a href="https://sites.google.com/site/findcommunities/" target="_blank" rel="noopener">Louvain method: Finding communities in large networks</a></p>]]></content>
    
    <summary type="html">
    
      &lt;h2 id=&quot;CytoSPADE&quot;&gt;&lt;a href=&quot;#CytoSPADE&quot; class=&quot;headerlink&quot; title=&quot;CytoSPADE&quot;&gt;&lt;/a&gt;CytoSPADE&lt;/h2&gt;&lt;blockquote&gt;
&lt;p&gt;A high-performance implementation of an interface for the Spanning-tree Progression Analysis of Density-normalized Events algorithm for tree-based analysis and visualization of this high-dimensional cytometry data&lt;/p&gt;
&lt;/blockquote&gt;
    
    </summary>
    
    
      <category term="杂记" scheme="http://yoursite.com/tags/%E6%9D%82%E8%AE%B0/"/>
    
  </entry>
  
  <entry>
    <title>The biology and function of fibroblasts in cancer</title>
    <link href="http://yoursite.com/2019/04/13/The-biology-and-function-of-fibroblasts-in-cancer/"/>
    <id>http://yoursite.com/2019/04/13/The-biology-and-function-of-fibroblasts-in-cancer/</id>
    <published>2019-04-13T07:51:43.000Z</published>
    <updated>2019-04-27T05:55:29.106Z</updated>
    
    <content type="html"><![CDATA[<h2 id="Abstract"><a href="#Abstract" class="headerlink" title="Abstract"></a>Abstract</h2><p>Fibroblasts are usually quiescent and become activated in a wound healing response. The governing principles of how quiescent, resting fibroblasts become ‘activated’ is still being unravelled, and exciting new information suggests that there might be two types of fibroblast activation profile: ‘reversible’ and ‘irreversible’, determined partly by epigenetic regulation. <font color="#F08080"><strong>Activated fibroblasts were identified predominantly by their expression of α-smooth muscle actin (αSMA; also known as ACTA2)</strong></font></p><p>(Fibroblast 一般是静默状态，在组织损伤时会被激活。activated fibroblast又可分为可逆的活化和不可逆的活化)</p><a id="more"></a><p><img src="https://i.loli.net/2019/04/13/5cb19e719d889.jpg" alt="Multi-step activation of fibroblasts"></p><p>Resting fibroblasts may share many features with MSC precursors.</p><p>MSC(Mesenchymal stem cells 间充质干细胞)</p><h2 id="Quiescent-versus-activated-fibroblasts"><a href="#Quiescent-versus-activated-fibroblasts" class="headerlink" title="Quiescent versus activated fibroblasts"></a>Quiescent versus activated fibroblasts</h2><p><img src="https://i.loli.net/2019/04/13/5cb1a2a3d2388.jpg" alt="Quiescent versus activated fibroblasts"></p><h2 id="Fibroblasts-and-mesenchymal-stem-cells"><a href="#Fibroblasts-and-mesenchymal-stem-cells" class="headerlink" title="Fibroblasts and mesenchymal stem cells"></a>Fibroblasts and mesenchymal stem cells</h2><p>it is well established that embryonic and umbilical cord‑derived fibroblasts and MSCs exhibit enhanced survival and stem cell‑like properties compared with those isolated from adult tissue. The collective evidence suggests that quiescent or resting fibroblasts are precursors of activated fibroblasts, which could also be called MSCs. Whether all activated fibroblasts are MSCs or only a subset that exhibits such properties remains to be determined and could depend on whether identical culture conditions are used</p><p>(activated fibroblast 也可称为MSC)</p><h2 id="Wound-healing-fibrosis-and-cancer"><a href="#Wound-healing-fibrosis-and-cancer" class="headerlink" title="Wound healing, fibrosis and cancer"></a>Wound healing, fibrosis and cancer</h2><h3 id="Acute-wound-healing"><a href="#Acute-wound-healing" class="headerlink" title="Acute wound healing"></a>Acute wound healing</h3><p>Once the wound is repaired, the number of activated fibroblasts decreases significantly owing to apoptosis, and the resting phenotype is probably restored. Such reversibility is the hallmark feature of tissue repair associated with wound healing.</p><h3 id="Cancer-fibrosis"><a href="#Cancer-fibrosis" class="headerlink" title="Cancer fibrosis"></a>Cancer fibrosis</h3><ul><li>Tumours are considered ‘wounds that do not heal’. Persistent emergence and accumulation of cancer cells in a given tissue represents an ongoing tissue injury, initiating a chronic wound healing response towards the cancer cells.(肿瘤可以被当成无法修复的组织损伤)</li><li>The term tumour fibrosis is interchangeable with desmoplastic reaction, tumour stroma and TME（结缔组织增生，肿瘤基质，TME）</li><li>Although the role of myofibroblasts in wound healing is well understood, their functional role in can- cer progression and metastasis is emerging as being complex and bimodal, with both cancer- promoting and cancer-restraining actions</li><li>The recruitment of stromal fibroblasts to the tumour is largely governed by the growth factors <strong>released by the cancer cells and the infiltrating immune cells</strong>. <font color="#F08080"><strong>TGFβ, PDGF and fibroblast growth factor 2 (FGF2)</strong></font> are key mediators of fibroblast activation in acute and chronic tissue damage. The recruitment of activated fibroblasts in many cancers is dependent on TGFβ</li><li>Many studies have shown that carcinoma in situ (CIS) already involves ‘reactive’ tumour fibrosis(原位癌时期就已经存在活化的fibroblast)。it might provide protection from invasive or<br>malignant conversion of CIS. Generally, the action of the cancer stroma is viewed as promoting cancer initiation and progression</li><li><font color="#F08080"><strong>IL-1β</strong></font> secretion by immune cells in early lesions emerges as a potential initiator of nuclear factor-κB (NF-κB) signalling in fibroblasts, instructing them to produce a pro-tumorigenic secretome</li><li>Reactive tumour stroma or fibrosis generally presents with an increased number of activated fibroblasts that usually express <font color="#F08080"><strong>αSMA or fibroblast activation protein (FAP)</strong></font> and exhibit increased deposition of collagens, fibrin and other ECM constituents compared with quies cent fibroblasts. The recruitment of new capillaries and accumulation of immune cells within the TME are mediated by many different growth factors, such as <font color="#F08080"><strong>VEGFA, PDGF, epidermal growth factor (EGF), IL-6 and IL-8</strong></font>, among others. In addition to cancer cell pro- duction of VEGFA, a source of host-derived VEGFA is activated fibroblasts.</li><li><font color="#F08080"><strong>Periostin and tenascin C</strong></font>, produced in part by activated fibroblasts, are generally absent in normal adult mammary tissue, but they become expressed in breast cancer</li></ul><p><img src="https://i.loli.net/2019/04/13/5cb1cf191edda.jpg" alt="Fibroblasts are highly plastic and exhibit multipotency"></p><h2 id="Fibroblast-function-and-heterogeneity"><a href="#Fibroblast-function-and-heterogeneity" class="headerlink" title="Fibroblast function and heterogeneity"></a>Fibroblast function and heterogeneity</h2><ul><li><p>It is now clear that many different markers can identify activated fibroblasts. Such markers include <font color="#FF0000"><strong>fibroblast- specific protein 1 (FSP1; also known as S100A4), vimentin, αSMA, FAP, PDGF receptor-α (PDGFRα), PDGFRβ, desmin and discoidin domain-containing receptor 2 (DDR2)</strong></font>.Of note, PDGF receptors (PDGFRα and PDGFRβ) and the associated downstream signalling can be pharmacologically targeted . <strong>FSP1 is a reliable marker to detect quiescent, non-proliferating (Ki67−) fibroblasts</strong></p></li><li><p>但是这些marker都不是特异的，比如FSP1 also identifies macrophages and possibly other immune cells and is expressed by some cancer cells. FAP is also present in a subset of CD45+<br>immune cells. Desmin and PDGFRβ are also expressed in perivascular cells</p></li><li><p>Loss of caveolin 1 (<font color="#F08080"><strong>CAV1</strong></font>) expression in breast tumour CAFs may define metabolically altered fibroblasts with pro-tumorigenic functions, yet high expression of CAV1 in CAFs could also facilitate tumour invasion via ECM remodelling（乳腺癌中CAV1减少可促进癌症，但是增加会通过ECM重塑肿瘤的侵袭性）</p></li><li><p>The heterogeneity of fibroblasts, in particular those that are activated from their quiescent state, could also depend on the origin of the precursor fibroblasts. Activated fibroblasts are reported to arise from bone marrow-derived precursors, MSCs, endothelial cells, liver and pancreas stellate cells, resting tissue fibroblast and possibly from some types of epithelial cell(Fibroblast 的异质性与它的起源有关，相应的功能也可能有很大区别)</p><p><img src="https://i.loli.net/2019/04/13/5cb1d2a8eb4af.jpg" alt="A proposed classification of subtypes of fibroblasts on the basis of function"></p><h3 id="Epigenetic-regulation-of-fibroblasts"><a href="#Epigenetic-regulation-of-fibroblasts" class="headerlink" title="Epigenetic regulation of fibroblasts"></a>Epigenetic regulation of fibroblasts</h3><ul><li><p>The signals that mediate the transition of resting fibroblasts into CAFs in tumours are probably complex, but in culture some of the phenotypic features associated with CAFs can be induced by TGFβ1. Nevertheless, emerging data suggest that the irreversible activation of fibroblasts might be driven by epigenetic alterations.(沉默Fibroblast向CAF转化的过程可能是由表观遗传调控的)</p></li><li><p>Studies with human breast tumours show that stromal cells (presumably fibroblasts) have unique epigenetic changes that are not observed in fibroblasts from normal mammary tissue</p></li><li>When FAFs are treated with the demethylating agent 5-azacytidine, the proliferation rate is reduced and collagen I synthesis and αSMA expression is decreased. Hypermethylation of RAS protein activator like 1 (RASAL1) and down regulation of RASAL1 protein lead to de novo activation of RAS in kidney FAFs but not in fibroblasts isolated from normal tissue or fibroblasts associated with acute kidney injury(使用去甲基化药物后，肿瘤中胶原减少，αSMA减少。RASAL1的过甲基化激活肾脏FAF中的RAS)</li><li>Prostate stromal cells with <strong>over-expression</strong> of the epigenetic regulator high-mobility group AT-hook 2 (<font color="#FF0000"><strong>HMGA2</strong></font>) were sufficient to induce prostatic intraepithelial neoplasia</li><li>An epigenetic switch implicating the regulation of leukaemia inhibitory factor (LIF) may result in the <strong>sustained and proinvasive functions</strong> of CAFs, via enhanced Janus kinase 1 ( <font color="#F08080"><strong>JAK1</strong></font>)–signal transducer and activator of transcription 3 ( <font color="#F08080"><strong>STAT3</strong></font>) activation</li></ul><h2 id="CAFs-positive-regulators-of-cancer"><a href="#CAFs-positive-regulators-of-cancer" class="headerlink" title="CAFs: positive regulators of cancer"></a>CAFs: positive regulators of cancer</h2><h3 id="CAFs-in-tumorigenesis"><a href="#CAFs-in-tumorigenesis" class="headerlink" title="CAFs in tumorigenesis"></a>CAFs in tumorigenesis</h3><p>The ability of CAFs to influence tumour growth was partly dependent on their ability to induce angiogenesis by CAF- derived stromal cell-derived factor 1 (SDF1; also known as <font color="#FF0000"><strong>CXCL12</strong></font>)</p></li></ul>]]></content>
    
    <summary type="html">
    
      &lt;h2 id=&quot;Abstract&quot;&gt;&lt;a href=&quot;#Abstract&quot; class=&quot;headerlink&quot; title=&quot;Abstract&quot;&gt;&lt;/a&gt;Abstract&lt;/h2&gt;&lt;p&gt;Fibroblasts are usually quiescent and become activated in a wound healing response. The governing principles of how quiescent, resting fibroblasts become ‘activated’ is still being unravelled, and exciting new information suggests that there might be two types of fibroblast activation profile: ‘reversible’ and ‘irreversible’, determined partly by epigenetic regulation. &lt;font color=&quot;#F08080&quot;&gt;&lt;strong&gt;Activated fibroblasts were identified predominantly by their expression of α-smooth muscle actin (αSMA; also known as ACTA2)&lt;/strong&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p&gt;(Fibroblast 一般是静默状态，在组织损伤时会被激活。activated fibroblast又可分为可逆的活化和不可逆的活化)&lt;/p&gt;
    
    </summary>
    
      <category term="paper" scheme="http://yoursite.com/categories/paper/"/>
    
    
      <category term="cancer" scheme="http://yoursite.com/tags/cancer/"/>
    
  </entry>
  
  <entry>
    <title>SPTLC2 +  TGF-β活化&amp;记忆性CD8 T 细胞的招募 + cDC1的亚群介导对于中性粒细胞的招募</title>
    <link href="http://yoursite.com/2019/04/12/SPTLC2%20+%20%20TGF-%CE%B2%E6%B4%BB%E5%8C%96&amp;%E8%AE%B0%E5%BF%86%E6%80%A7CD8%20T%20%E7%BB%86%E8%83%9E%E7%9A%84%E6%8B%9B%E5%8B%9F%20+%20cDC1%E7%9A%84%E4%BA%9A%E7%BE%A4%E4%BB%8B%E5%AF%BC%E5%AF%B9%E4%BA%8E%E4%B8%AD%E6%80%A7%E7%B2%92%E7%BB%86%E8%83%9E%E7%9A%84%E6%8B%9B%E5%8B%9F/"/>
    <id>http://yoursite.com/2019/04/12/SPTLC2 +  TGF-β活化&amp;记忆性CD8 T 细胞的招募 + cDC1的亚群介导对于中性粒细胞的招募/</id>
    <published>2019-04-12T13:34:49.000Z</published>
    <updated>2019-05-20T05:16:10.002Z</updated>
    
    <content type="html"><![CDATA[<h2 id="HSAN-I-相关SPTLC2缺失通过抑制T-细胞代谢抑制CD8-T细胞对于感染的反应"><a href="#HSAN-I-相关SPTLC2缺失通过抑制T-细胞代谢抑制CD8-T细胞对于感染的反应" class="headerlink" title="HSAN-I 相关SPTLC2缺失通过抑制T 细胞代谢抑制CD8 T细胞对于感染的反应"></a>HSAN-I 相关SPTLC2缺失通过抑制T 细胞代谢抑制CD8 T细胞对于感染的反应</h2><p><a href="https://www.cell.com/immunity/fulltext/S1074-7613(19" target="_blank" rel="noopener">Loss of Neurological Disease HSAN-I-Associated Gene <em>SPTLC2</em> Impairs CD8+ T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness</a>)</p><p>Immmunity, 2019.03</p><a id="more"></a><p>SPTLC2(serine palmitoyltransferase subunit)</p><p>SPTLC2 mutations are associated with the neurological disorder HSAN-I, in which patients get frequent infections, attributed to loss of pain sensation and failure to seek treatment for minor injuries. Wu et al. show that protective CD8+ T cell responses are defective in HSAN-I patients and that CD8+ T cells require SPTLC2-mediated sphingolipid synthesis to promote T cell metabolic fitness.</p><p><em>Sptlc2</em> deficiency reduced <strong>sphingolipid biosynthetic flux and led to prolonged activation of the mechanistic target of rapamycin complex 1 (mTORC1), endoplasmic reticulum (ER) stress, and CD8 + T cell death</strong>. Protective CD8 + T cell responses in HSAN-I patient PBMCs and <em>Sptlc2</em>-deficient mice were restored by supplementing with sphingolipids and pharmacologically inhibiting ER stress-induced cell death. Therefore, SPTLC2 underpins protective immunity by translating extracellular stimuli into intracellular anabolic signals and antagonizes ER stress to promote T cell metabolic fitness.</p><p><img src="https://i.loli.net/2019/04/12/5cb073b2d43d4.jpg" alt></p><h2 id="角质形成细胞介导的TGF-β活化维持皮肤对于记忆性CD8-T-细胞的招募"><a href="#角质形成细胞介导的TGF-β活化维持皮肤对于记忆性CD8-T-细胞的招募" class="headerlink" title="角质形成细胞介导的TGF-β活化维持皮肤对于记忆性CD8 T 细胞的招募"></a>角质形成细胞介导的TGF-β活化维持皮肤对于记忆性CD8 T 细胞的招募</h2><p><a href="https://www.cell.com/immunity/fulltext/S1074-7613(19" target="_blank" rel="noopener">Keratinocyte-Mediated Activation of the Cytokine TGF-β Maintains Skin Recirculating Memory CD8+ T Cells</a>)</p><p>Regulated activation of the cytokine TGF-β by integrins α vβ 6 and α vβ 8 expressed on keratinocytes is required for residence of epidermal-resident memory T cells, but whether skin-derived signals also affect recirculating memory cells in the skin remains unclear. Here, we show that <strong>after resolution of skin vaccinia virus (VV) infection, antigen-specific circulating memory CD8 + T cells migrated into skin</strong>. In mice lacking α vβ 6 and α vβ 8 integrins ( <em>Itgb6</em> −/− <em>Itgb8</em> fl/fl <em>-</em>K14-cre), the absence of epidermal-activated TGF-β resulted in a gradual loss of E- or P-selectin-binding central and peripheral memory populations, which were rescued when skin entry was inhibited. Skin recirculating memory cells were required for optimal host defense against skin VV infection. These data demonstrate that skin migration can persist after resolution of local skin infection and that the cytokine environment within this nonlymphoid tissue shapes the differentiation state and persistence of the central and peripheral memory-T-cell pool.</p><p><img src="https://i.loli.net/2019/04/12/5cb07f58b3da3.jpg" alt></p><h2 id="cDC1的一个亚群通过VEGFα介导的对于中性粒细胞的募集控制皮肤感染"><a href="#cDC1的一个亚群通过VEGFα介导的对于中性粒细胞的募集控制皮肤感染" class="headerlink" title="cDC1的一个亚群通过VEGFα介导的对于中性粒细胞的募集控制皮肤感染"></a>cDC1的一个亚群通过VEGFα介导的对于中性粒细胞的募集控制皮肤感染</h2><p><a href="https://www.cell.com/immunity/fulltext/S1074-7613(19" target="_blank" rel="noopener">A Subset of Type I Conventional Dendritic Cells Controls Cutaneous Bacterial Infections through VEGFα-Mediated Recruitment of Neutrophils</a>)</p><p>皮肤常规树突细胞（cDC）有两种不同的子集cDC1和cDC2存在，从而维持对病原体的免疫和对自身微生物群耐受的平衡。本文作者检测了皮肤cDC1s和cDC2s在细菌尤其是痤疮丙酸杆菌感染期间的作用。 cDC1s，而不是cDC2s，通过控制炎症部位的中性粒细胞募集及其存活和功能来调节对真皮中痤疮丙酸杆菌的免疫应答的程度。单细胞mRNA测序显示，该调节依赖于由一小部分活化的<font color="#F08080"><strong>EpCAM + CD59 + Ly-6D + cDC1s</strong></font>细胞分泌的细胞因子<font color="#F08080"><strong>VEGF-α</strong></font>。在金黄色葡萄球菌，卡介苗或大肠杆菌感染期间以及在人皮肤中的细菌损伤模型中也观察到真皮cDC1对中性粒细胞的募集作用。因此，皮肤cDC1是皮肤免疫中先天反应的必需调节剂，并且具有超出经典抗原呈递的作用。</p><p>In the skin, two subsets of ontogenetically distinct and functionally specialized conventional DCs (cDCs) exist: cDC1s, identified in mice as expressing <font color="#F08080"><strong>CD103 (integrin aE) and XCR1</strong></font>; and cDC2s, expressing <font color="#F08080"><strong>CD11b (integrin aM) and SIRPa</strong></font></p>]]></content>
    
    <summary type="html">
    
      &lt;h2 id=&quot;HSAN-I-相关SPTLC2缺失通过抑制T-细胞代谢抑制CD8-T细胞对于感染的反应&quot;&gt;&lt;a href=&quot;#HSAN-I-相关SPTLC2缺失通过抑制T-细胞代谢抑制CD8-T细胞对于感染的反应&quot; class=&quot;headerlink&quot; title=&quot;HSAN-I 相关SPTLC2缺失通过抑制T 细胞代谢抑制CD8 T细胞对于感染的反应&quot;&gt;&lt;/a&gt;HSAN-I 相关SPTLC2缺失通过抑制T 细胞代谢抑制CD8 T细胞对于感染的反应&lt;/h2&gt;&lt;p&gt;&lt;a href=&quot;https://www.cell.com/immunity/fulltext/S1074-7613(19&quot; target=&quot;_blank&quot; rel=&quot;noopener&quot;&gt;Loss of Neurological Disease HSAN-I-Associated Gene &lt;em&gt;SPTLC2&lt;/em&gt; Impairs CD8+ T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness&lt;/a&gt;)&lt;/p&gt;
&lt;p&gt;Immmunity, 2019.03&lt;/p&gt;
    
    </summary>
    
      <category term="paper" scheme="http://yoursite.com/categories/paper/"/>
    
    
      <category term="immunity" scheme="http://yoursite.com/tags/immunity/"/>
    
  </entry>
  
  <entry>
    <title>Serine Metabolism Supports Macrophage IL-1b production</title>
    <link href="http://yoursite.com/2019/04/12/Serine-Metabolism-Supports-Macrophage-IL-1b-production/"/>
    <id>http://yoursite.com/2019/04/12/Serine-Metabolism-Supports-Macrophage-IL-1b-production/</id>
    <published>2019-04-12T08:02:30.000Z</published>
    <updated>2019-04-27T05:54:35.678Z</updated>
    
    <content type="html"><![CDATA[<p><a href="https://doi.org/10.1016/j.cmet.2019.01.014" target="_blank" rel="noopener">Serine Metabolism Supports Macrophage IL-1b Production </a></p><a id="more"></a><p> <img src="https://i.loli.net/2019/04/12/5cb043518e049.jpg" alt></p><p>&nbsp;</p><h2 id="highlight"><a href="#highlight" class="headerlink" title="highlight"></a>highlight</h2><ul><li>Serine deprivation diminishes LPS-induced IL-1b mRNA expression </li><li>LPS stimulates serine generation of glycine for glutathione synthesis</li><li>Glutathione is necessary to maintain LPS induction of IL-1bproduction </li><li>Inhibition of de novo serine synthesis promotes survival of mice exposed to LPS </li></ul><h2 id="Result"><a href="#Result" class="headerlink" title="Result"></a>Result</h2><h3 id="Serine-Is-Necessary-for-Optimal-IL-1b-Gene-Expression"><a href="#Serine-Is-Necessary-for-Optimal-IL-1b-Gene-Expression" class="headerlink" title="Serine Is Necessary for Optimal IL-1b Gene Expression"></a>Serine Is Necessary for Optimal IL-1b Gene Expression</h3><p> <img src="https://i.loli.net/2019/04/12/5cb0450d4943f.jpg" alt></p><p>ECAR:胞外产酸能力，间接反映糖酵解水平</p><p>OCR：检测耗氧量</p><p>&nbsp;</p><h3 id="Serine-Metabolism-Supports-LPS-Induction-of-GSH-synthesis-which-Is-Required-for-IL-1b-Gene-Expression"><a href="#Serine-Metabolism-Supports-LPS-Induction-of-GSH-synthesis-which-Is-Required-for-IL-1b-Gene-Expression" class="headerlink" title="Serine Metabolism Supports LPS Induction of GSH synthesis, which Is Required for IL-1b Gene Expression"></a>Serine Metabolism Supports LPS Induction of GSH synthesis, which Is Required for IL-1b Gene Expression</h3><p> <img src="https://i.loli.net/2019/04/12/5cb045235a5a2.jpg" alt></p><p>&nbsp;</p><h3 id="Serine-Deprivation-Diminishes-IL-1b-Gene-Expression-of-BMDMs-without-Altering-Inflammation-Associated-Gene-Networks-or-Inflammasome-Activation"><a href="#Serine-Deprivation-Diminishes-IL-1b-Gene-Expression-of-BMDMs-without-Altering-Inflammation-Associated-Gene-Networks-or-Inflammasome-Activation" class="headerlink" title="Serine Deprivation Diminishes IL-1b Gene Expression of BMDMs without Altering Inflammation-Associated Gene Networks or Inflammasome Activation"></a>Serine Deprivation Diminishes IL-1b Gene Expression of BMDMs without Altering Inflammation-Associated Gene Networks or Inflammasome Activation</h3><p><img src="https://i.loli.net/2019/04/12/5cb044648650a.jpg" alt></p><p>&nbsp;</p><h3 id="De-Novo-Serine-Synthesis-Is-Required-for-LPS-Responses-In-Vivo"><a href="#De-Novo-Serine-Synthesis-Is-Required-for-LPS-Responses-In-Vivo" class="headerlink" title="De Novo Serine Synthesis Is Required for LPS Responses In Vivo"></a>De Novo Serine Synthesis Is Required for LPS Responses In Vivo</h3><p><img src="https://i.loli.net/2019/04/12/5cb044d36de7c.jpg" alt></p><p>&nbsp;</p>]]></content>
    
    <summary type="html">
    
      &lt;p&gt;&lt;a href=&quot;https://doi.org/10.1016/j.cmet.2019.01.014&quot; target=&quot;_blank&quot; rel=&quot;noopener&quot;&gt;Serine Metabolism Supports Macrophage IL-1b Production &lt;/a&gt;&lt;/p&gt;
    
    </summary>
    
      <category term="paper" scheme="http://yoursite.com/categories/paper/"/>
    
    
      <category term="immunity" scheme="http://yoursite.com/tags/immunity/"/>
    
  </entry>
  
  <entry>
    <title>fibroblast in cancer</title>
    <link href="http://yoursite.com/2019/04/09/fibroblast-in-cancer/"/>
    <id>http://yoursite.com/2019/04/09/fibroblast-in-cancer/</id>
    <published>2019-04-09T06:53:51.000Z</published>
    <updated>2019-04-27T05:53:26.430Z</updated>
    
    <content type="html"><![CDATA[<p><a href="doi:10.1038/nrc1877" target="_blank" rel="noopener">Fibroblasts in cancer</a></p><p>The important functions of fibroblasts include the deposition of extracellular matrix (ECM), regulation of epithelial differentiation, regulation of inflammation, and involvement in wound healing</p><a id="more"></a><h2 id="The-tumour-stroma"><a href="#The-tumour-stroma" class="headerlink" title="The tumour stroma"></a>The tumour stroma</h2><p>Normal stroma in most organs contains a minimal number of fibroblasts in association with a physiological ECM. Reactive stroma is associated with an increased number of fibroblasts, enhanced capillary density, and type-I-collagen and fibrin deposition.</p><p>&nbsp;</p><p><img src="https://i.loli.net/2019/04/09/5cac5243ebdef.jpg" alt></p><p>In chickens that are cancer-prone because they have been infected with Rous sarcoma virus, wounding leads to invasive carcinomas within tissues that would other- wise remain tumour-free. This demonstrates that reactive stroma provides oncogenic signals to facilitate tumorigenesis.</p><p>&nbsp;</p><p>Vascular endothelial growth factor (VEGF, also known as vascular permeability factor (VPF)) has a central role in the emergence of the reactive stroma</p><p><strong>VEGF induces microvascular permeability</strong>, which leads to the extravasation of plasma proteins such as fibrin, which in turn attract an influx of fibroblasts, inflammatory cells and endothelial cells. These cells produce ECM(extracellular matrix) that is rich in fibronectin and type I collagen, both of which are conducive to initiating tumour angiogenesis</p><p>carcinoma in situ (CIS)</p><p>&nbsp;</p><p><strong>Tenascin C</strong> is absent in the normal adult mammary gland, but  expression is regularly seen in mammary tumours. Increased tenascin-C expression correlates with poor prognosis for both <strong>breast cancer and bladder cancer</strong>.</p><p>&nbsp;</p><p>There are several well-established indicators of fibroblast phenotype, but none of them are both exclusive to fibroblasts and present in all fibroblasts (see table). Among all of the known markers, fibroblast-specific protein 1 (<strong>FSP1</strong>) seems to provide the best specificity for detecting fibroblasts in vivo. <strong>Desmin</strong> is a specific marker for fibroblasts in the skin, whereas it is strongly expressed in muscle cells in other sites</p><p>Fetal skin fibroblasts express high levels of collagen types I and V, whereas fetal lung fibroblasts do not. Also, fetal lung fibroblasts exclusively express the lung-specific forkhead family transcription factors <strong>FOXF1</strong> and <strong>FOXP1</strong></p><p>&nbsp;</p><p>Injection of <strong>L-3,4 dehydroproline</strong> (which inhibits the formation of collagen fibrils) increases tumour cell invasion in a mouse model of B16F10 melanoma subcutaneous tumours</p><p>&nbsp;</p><p><img src="https://i.loli.net/2019/04/09/5cacbb9c1f275.jpg" alt></p><p>&nbsp;</p><h2 id="Carcinoma-associated-fibroblasts"><a href="#Carcinoma-associated-fibroblasts" class="headerlink" title="Carcinoma-associated fibroblasts"></a>Carcinoma-associated fibroblasts</h2><p>In the absence of electron microscopy validation, CAFs are commonly identified by their expression of <font color="#F08080"><strong>α-smooth-muscle actin</strong></font></p><p>The signals that mediate the transition of a normal fibroblast into a CAF are not fully understood. In culture, phenotypic features of CAFs can be induced by transforming growth factor-β (TGFβ), which mediates fibroblast activation during wound healing and organ fibrosis.Therefore, similar pathways might also be responsible for the emergence of CAFs in tumours.</p><p>&nbsp;</p><p><img src="https://i.loli.net/2019/04/09/5cacbbf68b1dc.jpg" alt></p><p>&nbsp;</p><h2 id="Growth-factors-and-fibroblasts"><a href="#Growth-factors-and-fibroblasts" class="headerlink" title="Growth factors and fibroblasts"></a>Growth factors and fibroblasts</h2><p>Tumour stroma volume and composition are partly governed by the response of fibroblasts to the pro-fibrotic growth factors that are released by the cancer cells— for example, TGFβ, platelet-derived growth factor (PDGF) and fibroblast growth factor 2 (FGF2)</p><p>PDGF is another growth factor that is secreted by can- cer cells and correlates with cancer progression.As opposed to TGFβ, PDGF induces the proliferation of fibroblasts, but does not induce the acquisition of an activated phenotype that is associated with excessive ECM deposition</p><p>&nbsp;</p><h2 id="EMT-as-a-source-of-CAFs"><a href="#EMT-as-a-source-of-CAFs" class="headerlink" title="EMT as a source of CAFs"></a>EMT as a source of CAFs</h2><p>In epithelial-to-mesenchymal transition (EMT), epithelial cells lose cell–cell contacts and acquire mesenchymal properties. Cancer cells undergoing EMT develop invasive and migratory abilities</p><p>EMT involving normal epithelial cells that are adjacent to malignant cancer cells might also contribute to the emergence of CAFs</p><p>&nbsp;</p><h2 id="The-role-of-CAFs-in-the-initiation-of-cancer"><a href="#The-role-of-CAFs-in-the-initiation-of-cancer" class="headerlink" title="The role of CAFs in the initiation of cancer"></a>The role of CAFs in the initiation of cancer</h2><p>Overexpression of TGFβ and/or hepatocyte growth factor (<font color="#F08080"><strong>HGF</strong></font>) in mouse fibroblasts induces the initiation of breast cancer within the normal human epithelium.</p><p>&nbsp;</p><p><img src="https://i.loli.net/2019/04/12/5cb0933d9c560.jpg" alt></p><p>&nbsp;</p><h2 id="The-role-of-CAFs-in-the-progression-of-cancer"><a href="#The-role-of-CAFs-in-the-progression-of-cancer" class="headerlink" title="The role of CAFs in the progression of cancer"></a>The role of CAFs in the progression of cancer</h2><p>Ras-transformed human MCF-7 breast cancer cells (which form tumours and metastasize independent of oestrogen) were co-injected subcutaneously into nude mice in suspension with CAFs or normal fibroblasts The results showed that xenografts containing CAFs grew larger than xenografts infused with normal fibroblasts<br>Such enhanced growth was associated with increased cancer-cell proliferation (but not increased fibroblast pro- liferation) and more angiogenesis, indicating that CAFs might have a bi-modal effect during tumorigenesis</p><p>既能促进癌细胞的增殖，又能促进血管的生成</p><p>CAF-derived stromal- cell-derived factor 1 (<font color="#F08080"><strong>SDF1</strong></font>) mediates the recruitment of bone-marrow-derived endothelial cells and directly increases the proliferation of MCF-Ras cancer cells</p><p>Activated fibroblasts are a source of ECM-degrading proteases such as the MMPs. MMPs probably allow cancer cells to cross tissue boundaries and escape the primary tumour site.</p><font color="#F08080"><strong>MMP3</strong></font> (also known as stromelysin 1) is highly expressed in fibroblasts<br><br>MMP3 directly cleaves the extra- cellular domain of E-cadherin, prompting normal mammary epithelial cells to disaggregate and undergo EMT, promoting cancer-cell invasiveness. MMP1 also shows such a tumour-promoting effect. The protease-activated receptor <font color="#F08080"><strong>PAR1</strong></font>, which is a tethered-ligand receptor, is activated by proteolytic cleavage of the extracellular domain by MMP1, promoting cancer cell migration and invasion through PAR1-dependent Ca2+ signals<br><br>(MMP3和MMP1切割E-钙黏蛋白的胞外结构域，从而激活PAR1。PAR1通过Ca2+信号促进癌细胞的迁移)<br><br>&nbsp;<br><br>## The role of CAFs in metastasis<br><br>only the melanoma cells that metastasized were influenced by fibroblasts. This indicates that specific stimuli provided by fibroblasts create a niche that promotes the growth of subsets of cancer cells at distant sites. Tumour growth and metastasis in FSP1-deficient mice (FSP1-deficient fibroblasts show decreased motility) is significantly reduced.<br><br>&nbsp;&nbsp;<br><br>## Fibroblasts and TGFβ<br><br>TGFβ has a role in the recruitment of fibroblasts. However, TGFβ is also the most prominent of the factors within the tumour micro- environment that are known to induce EMT of cancer cells. Before the initiation of cancer, and during the early stages of carcinogenesis, TGFβ probably functions as a tumour suppressor. By contrast, during advanced stages of cancer, TGFβ signalling promotes cancer progression and metastasis.<br><br>In normal tissues, the anti-proliferative and proapoptotic response of epithelial cells to TGFβ might limit the growth of normal epithelium and the emergence of malignant carcinomas. With regard to fibroblasts,TGFβ facilitates fibroblast–epithelial-cell interactions, which further suppress cancer initiation. In advanced cancer, on the other hand, the anti-proliferative effect of TGFβ is progressively lost — instead, it facilitates EMT of cancer cells, potentially promoting invasiveness and metastasis. Signalling pathways that are implicated in TGFβ-mediated EMT involve  <font color="#F08080"><strong>Smad</strong></font> signalling, the <font color="#F08080"><strong>phosphatidylinositol-3-kinase–Akt</strong></font> pathway and signalling through <font color="#F08080"><strong>RHOA</strong></font> and <font color="#F08080"><strong>p38 MAPK</strong></font><p>(其中Smad可能是起决定作用的通路)</p><p>&nbsp;</p><p><img src="https://i.loli.net/2019/04/12/5cb0937f9bfc0.jpg" alt></p><p>&nbsp;</p><h2 id="Fibroblasts-in-the-host-defence-against-cancer"><a href="#Fibroblasts-in-the-host-defence-against-cancer" class="headerlink" title="Fibroblasts in the host defence against cancer?"></a>Fibroblasts in the host defence against cancer?</h2><p>Fibroblasts that overexpress TGFβ and HGF promote tumorigenic outgrowth of normal breast epithelium, but such outgrowth is inhibited by ‘normal’ stromal fibroblasts. One possible mechanism for such a function of fibroblasts in host defence is modulation of the immune response. Fibroblasts are a signficant source of immune-modulatory cytokines such as interferon-γ, interleukin-6 and tumour-necrosis factor-α which can influence the mobilization of cytotoxic T lymphocytes, natural killer cells and macrophages. In this regard, it has also been suggested that normal fibroblasts help to prevent apoptosis of T cells</p><p>(活化的fibroblast促进癌症，normal fibroblast抑制癌症)</p><p>&nbsp;</p><h2 id="Therapies-to-target-activated-fibroblasts"><a href="#Therapies-to-target-activated-fibroblasts" class="headerlink" title="Therapies to target activated fibroblasts"></a>Therapies to target activated fibroblasts</h2><p>Fibroblast-directed therapy can be envisioned as either ‘to ablate’ or ‘to normalize’ CAFs. The cell-surface serine protease known as fibroblast activation protein (<font color="#F08080"><strong>FAP</strong></font>) emerges as a promising candidate for specifically targetting CAFs. FAP is not expressed by mature somatic tissues except for activated fibroblasts during wound healing and within tumour stroma.</p><p>HGF inhibits the activation and progression of tissue fibrosis in several animal models of chronic disease, and HGF overexpression prevents fibrosis in the liver and kidneys. However, numerous studies have implied that HGF promotes the malignant transformation of epithelial cells and also promotes cancer progression</p>]]></content>
    
    <summary type="html">
    
      &lt;p&gt;&lt;a href=&quot;doi:10.1038/nrc1877&quot; target=&quot;_blank&quot; rel=&quot;noopener&quot;&gt;Fibroblasts in cancer&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;The important functions of fibroblasts include the deposition of extracellular matrix (ECM), regulation of epithelial differentiation, regulation of inflammation, and involvement in wound healing&lt;/p&gt;
    
    </summary>
    
      <category term="paper" scheme="http://yoursite.com/categories/paper/"/>
    
    
      <category term="cancer" scheme="http://yoursite.com/tags/cancer/"/>
    
  </entry>
  
</feed>
